GLP-1 & Obesity
GLP-1 medicines treat obesity and diabetes, and have grown into one of the largest drug categories ever launched. Their reach extends past medicine, because a change in how much people eat moves whole consumer industries.
92 stocks
Increased
Reduced
Net increased
Funds Holding
3,457
Funds Holding Change
+284
Funds Holding Growth
+9%
Value
$607B
Holding in Top 10
427
Top 10 Change
+104
Top 10 Growth
+32%
Value Growth
+15%
New
417
Increased
1,383
Reduced
1,431
Closed
81
Capital Inflow
$19.4B
Capital Outflow
$18B
Net Capital Flow
+$1.45B
Capital Flow Change
+$8.74B
Calls
$5.92B
Puts
$7.1B
Net Calls
-$1.18B
Put/Call Ratio
1.2